LID.L Regulatory News (LID)

25 Apr 2008 11:27

LiDCO Group Plc25 April 2008 25 April 2008 LiDCO Group Plc ("LiDCO" or the "Company") Grant of Share Options The Board of LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company,announces that in accordance with the Company's Employee Share Option Schemes on24 April 2008 it granted the following options to subscribe for new ordinaryshares in the Company to two Directors and to the Company Secretary as follows: Director Number Exercise Price Exercise Period John Barry 350,000 7.5p 2011-2018 Paul Clifford 66,000 7.5p 2011-2018 Company Secretary John Rowland 25,000 7.5p 2011-2018 In addition, options over a further 685,120 new ordinary shares have beengranted to employees of the Company on the same terms. - ENDS - For further information, please contact: LiDCO PLC Terry O'Brien (CEO) Tel: +44 (0)20 7749 1500 John Rowland (Company Secretary) Theresa Wallis (Chairman) www.lidco.com Panmure Gordon Edward Farmer Tel: +44 (0) 20 7459 3600 edward.farmer@panmure.com Media enquiries: Abchurch Heather Salmond / Stephanie Cuthbert Tel: +44 (0) 20 7398 7718 stephanie.cuthbert@abchurch-group.com www.abchurch-group.com About LiDCO Group Plc LiDCO is a leading supplier of minimally invasive hemodynamic monitoringequipment and disposables. These are used primarily for the management ofhospital patients requiring critical care or at major cardiovascular risk.LiDCO's computer-based technology significantly reduces the complications(particularly infections) and costs associated with major surgery. Thetechnology was invented in the Department of Applied Physiology based at StThomas' Hospital, London. LiDCO is based in the UK and its shares are traded onAIM. For more information please see www.lidco.com. The Company's manufacturing facility is in Hoxton, London and its currentproducts are: * LiDCOplus and PulseCO monitors: these computer-based platforms are used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid volume (PPV% and SVV%) * LiDCO disposables: used in conjunction with the LiDCOplus Monitor for accurate measurement of cardiac output in a minimally invasive manner * LiDCOview: an easy-to-use graphical display of historical LiDCOplus hemodynamic data. Both clinical researchers and routine users can view beat-to-beat hemodynamic data collected with the LiDCOplus. LiDCOviewSE is the standard version of this tool and is available for free, allowing anyone to download and access data from the LiDCOplus. LiDCOviewPRO is the Professional version, allowing users to analyse, export and report the LiDCOplus data. A free trial of LiDCOviewPRO is available for evaluation purposes prior to purchase * LiDCOlive: a software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus or LiDCOrapid monitors * LiDCOrapid : our new cardiac output monitor designed specifically for use in the Operating Theatre for fluid and drug management at the point of care Distribution Network: The Company has now achieved registration of its products in 14 markets inEurope, the USA, Brazil, South Korea and Japan. It sells direct in the UK andUSA, and elsewhere through a worldwide network of speciality critical care andanesthesia distributors. This information is provided by RNS The company news service from the London Stock Exchange